文章摘要
贺涓涓,卫小梅,解东风,等.超声影像引导下糖皮质激素注射对不同肩周病变患者疗效的回顾性研究[J].中华物理医学与康复杂志,2019,41(1):37-41
扫码阅读全文 本文二维码信息
超声影像引导下糖皮质激素注射对不同肩周病变患者疗效的回顾性研究
  
DOI:DOI:10.3760/cma.j.issn.0254-1424.2019.01.008
中文关键词: 肩痛  超声引导  注射
英文关键词: Shoulder pain  Ultrasound  Glucocorticoids
基金项目:国家自然科学基金项目资助(81201508);广东省自然科学基金项目资助(2015A030313158)
作者单位
贺涓涓 中山大学附属第三医院康复医学科广州 510630 
卫小梅 中山大学附属第三医院康复医学科广州 510630 
解东风 中山大学附属第三医院康复医学科广州 510630 
王庄富 中山大学附属第三医院康复医学科广州 510630 
赵妃 中山大学附属第三医院康复医学科广州 510630 
麦艺颖 中山大学附属第三医院康复医学科广州 510630 
汤伟健 中山大学附属第三医院康复医学科广州 510630 
窦祖林 中山大学附属第三医院康复医学科广州 510630 
姜丽 中山大学附属第三医院康复医学科广州 510630 
摘要点击次数: 3758
全文下载次数: 3589
中文摘要:
      目的 回顾分析超声影像引导下糖皮质激素注射对不同肩周病变的疗效。 方法 收集2017年4月至9月期间在中山大学附属第三医院康复科门诊接受超声影像引导糖皮质激素注射治疗、并完成3个月随访的肩痛患者临床资料。根据患者注射方案不同分为3组,方案1组给予单一肩峰下滑囊注射;方案2组给予肩峰下滑囊+喙突下滑囊联合注射;方案3组给予肩峰下滑囊+肱二头肌长头腱鞘联合注射。采用肩关节疼痛与功能障碍指数(SPADI)量表分别比较各组患者注射治疗前、后肩关节疼痛及功能障碍评分。 结果 共纳入患者75例。与基线比较,3组患者注射后1周、1个月、3个月时其肩痛及肩关节功能障碍评分均显著改善。随访至注射后3个月时,发现方案1组和方案3组患者疼痛及功能障碍评分持续改善(P<0.0083);方案2组患者功能障碍评分持续改善(P<0.0083);随访3个月时疼痛评分与随访1个月时疼痛评分差异无统计学意义(P>0.05)。3组患者注射前及注射后相同时间点其疼痛及功能障碍评分组间差异均无统计学意义(P>0.05)。 结论 超声影像引导糖皮质激素注射治疗肩周病变患者疗效显著、效果稳定,不同肩周病变患者均可获得满意疗效。
英文摘要:
      Objective To analyze the effect of ultrasound-guided glucocorticoid injection on different pathologies of the shoulder retrospectively. Methods Clinical data were collected describing 75 patients with shoulder pain who received ultrasound-guided glucocorticoid injection and finished 3 month follow-ups in the rehabilitation clinic of the Third Affiliated Hospital of Sun Yat-sen University between April and September of 2017. The patients were divided into three groups based on their different injection sites: group 1 was injected at the subacromial bursa alone, group 2 was injected at both the subacromial bursa and the coracoid bursa, while group 3 was injected at the subacromial bursa and the long head of the tendon sheath of the biceps brachii. A shoulder pain and disability index (SPADI) was used to quantify the pain and disability of each patient before and after the injection. Results Significant improvement was observed in the average pain and disability scores of all groups at 1 week, 1 month and 3 months after the injection. Moreover, significant and continuous improvement was observed in the average pain and disability scores of groups 1 and 3, as well as the average disability score of group 2 from right after the injection until the last follow-up. However, no significant differences were found in the average pain score between one and three months after the injection. There was no significant difference among the 3 groups in the average pain and disability scores before and immediately after the injection. Conclusion Ultrasound-guided glucocorticoid injection is effective and persistent for treating shoulder pain with different pathologies.
查看全文   查看/发表评论  下载PDF阅读器
关闭